Beyond cancer vaccine, how did Merck’s oncology pipeline do at #ESMO26?
MADRID — Much of the coverage on Merck at the European Society for Medical Oncology congress centered on its Moderna-partnered cancer vaccine trial. But the company is actually at the meeting with more than two ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.